Document text
Principal Investigator: Stephen Leppla
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2022
Award: $51,366
Funding agency: National Institute of Allergy and Infectious Diseases
The monoclonal S9.6 antibody has the unique property of recognizing DNA/RNA hybrids in a sequence-independent manner. Previously, we popularized this antibody and made it available to hundreds of researchers. We worked with NIH tech transfer staff to license this antibody to several leading reagent supply companies. S9.6 has become a key tool for the study of R-loops, which are natural structures, but ones that become excessively abundant in certain pathological situations.
A polyclonal antibody recognizing DNA/RNA hybrids is the basis of hybrid capture ELISA-type commercial diagnostic assays for human papilloma virus (HPV) DNA in vaginal swabs. It follows that the S9.6 antibody offers a generic approach to detection and quantitation of any nucleic acid of known sequence. Development of this diagnostic platform could lead to methods for detection of any pathogen of interest.
During FY2022 we continued to improve methods for production of the S9.6 immunoglobulin (IgG) antibody in other formats including single-chain variable fragment (scFv), fragment antigen-binding region (Fab), and molecularly well-defined Fab-reporter conjugates. Thus, we prepared the S9.6 Fab as a recombinant protein equipped with a C-terminal sequence recognized by the sortase transpeptidase. After also producing secreted embryonic alkaline phosphatase (SEAP) with a Gly3 N-terminus, the two proteins were conjugated by sortase in excellent yield to produce a purified and fully defined S9.6 Fab-SEAP conjugate. Once this conjugate proved useful in various diagnostic assay formats (described below), we extended this work to produce the S9.6 Fab (heavy chain)-SEAP protein as a genetic fusion. Because SEAP exists only as a dimer, this genetic fusion protein is effectively bivalent, with an S9.6 Fab attached to each of the SEAP monomers in the dimer. All these S9.6 proteins were produced in Chinese hamster ovary (CHO) cells grown in suspension culture, an efficient system that can yield > 50 milligrams protein per liter.
The purified S9.6 antibody variants and conjugates were employed during FY2022 in a variety of assay formats for detection of RNA of Bacillus anthracis and Toxoplasma gondii, as models for future application to COVID RNA detection. In one successful format, hybrids produced from poly-biotinylated single-stranded DNA probes and complementary B. anthracis mRNA were captured on a polystreptavidin-coated assay plate and detected using S9.6 and HRP-conjugated anti-mouse IgG. We also established assays like the HPV ELISA assay, where hybrids are captured on surface-bound S9.6 IgG and then detected with an S9.6 Fab-SEAP conjugate.
To make S9.6-based assays more convenient for low-resource areas, we initiated work to implement a lateral flow assay. Our collaborator Marco Biamonte (DDTD, CA) developed an S9.6 IgG-gold nanoparticle conjugate, which we employed to identify SARS-CoV-2 specific DNA:RNA hybrids on a lateral flow strip. Further optimization of this format is continuing.
As previously described, work with S9.6 as a diagnostic tool would be aided by understanding the basis for the specificity of the antibody. Our collaborators Charles Bou-Nader and Jinwei Zhang of NIDDK had successfully produced crystals of the S9.6 Fab in complex with a small DNA/RNA hybrid. This work has now been completed by publication of the structure of the complex. Having a structure will facilitate rational approaches to optimizing the selectivity of the antibody.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Alkaline Phosphatase><Antibodies><Antibody Specificity><Antigen Binding Fragment><Area><Assay><B anthracis><B. anthracis><Bacillus anthracis><Bioassay><Biologic Assays><Biological Assay><C-terminal><CHO Cells><COVID><COVID detection><COVID-19 virus><COVID19 virus><Chimera Protein><Chimeric Proteins><Chinese Hamster Ovary Cell><Clinical Treatment Moab><CoV disease><CoV-2><CoV2><Complex><Crystallization><DNA><DNA Hybridization Probes><DNA Probes><Deoxyribonucleic Acid><Detection><Development><Diagnostic Method><Diagnostic Procedure><Diagnostic Reagent Kits><Diagnostic Technique><Dot Immunoblotting><ELISA><Embryo><Embryonic><Enzyme Gene><Enzyme-Linked Immunosorbent Assay><Enzymes><Equipment><Fab Fragments><Fab Immunoglobulins><Fusion Protein><Future><Genetic><HPV><Human Papilloma Virus><Human Papillomavirus><Hybrids><Immune Globulins><Immunoglobulin, F(ab) Fragment><Immunoglobulins><Infectious Human Wart Virus><Investigators><Lateral><Lead><Licensing><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><MAb Therapeutics><Messenger RNA><Methods><Mice><Mice Mammals><Modeling><Modification><Molecular><Monoclonal Antibodies><Murine><Mus><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Non-Polyadenylated RNA><Nucleic Acids><Pathogenesis><Pathologic><Pb element><Peptidyl Transferases><Peptidyl Translocases><Peptidyltransferase><Phosphoprotein Phosphatase><Phosphoprotein Phosphatase-2C><Phosphoprotein Phosphohydrolase><Preparation><Production><Property><Protein Phosphatase C><Protein Phosphatase Gene><Protein Phosphatase-1><Protein Phosphatase-2A><Protein phosphatase><Proteins><Publications><RNA><RNA Gene Products><Reagent><Recombinant Proteins><Recombinants><Reporter><Research Personnel><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Ribonucleic Acid><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV-1><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scientific Publication><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Single-Stranded DNA><Stress><Structure><Surface><Suspension Culture><Swab><System><T gondii><T. gondii><Testing><Therapeutic Agents><Therapeutic Monoclonal Antibodies><Toxoplasma gondii><Transpeptidases><United States National Institutes of Health><Vagina><Vaginal><Variant><Variation><Viral><Work><Wuhan coronavirus><alkaline phosphomonoesterase><anthracis><antigen binding><antigen bound><base><corona virus disease><coronavirus detection><coronavirus disease><coronavirus disease 2019 virus><coronavirus disease detection><coronavirus disease-19 virus><coronavirus of pandemic concern><coronavirus of pandemic potential><coronavirus with pandemic potential><cost><detect COVID><detect coronavirus><detect coronavirus disease><detection method><detection procedure><detection technique><developmental><diagnostic assay><diagnostic kit><diagnostic platform><diagnostic system><diagnostic tool><dimer><dot blotting><enzyme linked immunoassay><glycerophosphatase><gold nano particle><gold nanoparticle><hCoV19><heavy metal Pb><heavy metal lead><improved><interest><lateral flow assay><lateral flow test><mAbs><mRNA><microbial><milligram><monoclonal antibody drugs><monomer><nCoV2><nano gold><nanoGold><pandemic coronavirus><pandemic threat coronavirus><pathogen><point-of-care diagnostics><polyclonal antibody><severe acute respiratory syndrome-CoV><sortase><srtA gene product><success><test kit><therapeutic mAbs><tool><viral DNA><viral RNA><viral detection><virus DNA><virus RNA><virus detection><wart virus>